Aura Biosciences, Inc. (AURA)

USD 5.45

(2.83%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019
Revenue - - - - -
Cost of Revenue 1.29 Million 1.17 Million 835 Thousand 831 Thousand 509 Thousand
Gross Profit -1.29 Million -1.17 Million -835 Thousand -831 Thousand -509 Thousand
Operating Expenses 84.99 Million 60.29 Million 35.25 Million 22.2 Million 24.14 Million
Selling, General and Administrative Expenses 19.75 Million 18.05 Million 10.08 Million 4.16 Million 4.52 Million
Research and Development Expenses 65.23 Million 42.23 Million 25.16 Million 18.04 Million 19.61 Million
Other Expenses - -5000.00 -11 Thousand 3000.00 -44 Thousand
Cost and Expenses 84.99 Million 60.29 Million 35.25 Million 22.2 Million 24.14 Million
Operating Income -84.99 Million -60.29 Million -35.25 Million -22.2 Million -24.14 Million
Interest Expense - - 13 Thousand 3000.00 5000.00
Income Tax Expense 137 Thousand -1.53 Million -830 Thousand 3000.00 5000.00
Earnings before Tax -76.27 Million -58.76 Million -35.25 Million -22.2 Million -24.2 Million
Net Income -76.4 Million -57.23 Million -34.42 Million -22.2 Million -24.2 Million
Earnings Per Share Basic -1.93 -1.91 -1.18 -0.76 -0.83
Earnings Per Share Diluted -1.93 -1.91 -1.18 -0.76 -0.83
Weighted Average Shares Outstanding 39.62 Million 29.93 Million 29.21 Million 29.21 Million 29.21 Million
Weighted Average Shares Outstanding (Diluted) 39.62 Million 29.93 Million 29.21 Million 29.21 Million 29.21 Million
Gross Margin - - - - -
EBIT Margin - - - - -
Profit Margin - - - - -
EBITDA -83.69 Million -59.11 Million -34.41 Million -21.37 Million -23.63 Million
Earnings Before Tax Margin - - - - -

Income Statement Charts